Syndecan‑1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target-Reference-Cited by-同舟云学术

Syndecan‑1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target

Published:2023-07-04 Issue:2 Volume:26 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Akca Duygu¹,Simon Adrian²,Buettner Reinhard²,Bruns Christiane³,Schroeder Wolfgang³,Zander Thomas⁴,Gebauer Florian³,Quaas Alexander²

Affiliation:

1. Department of Pathology, Tekirdag Dr. Ismail Fehmi Cumalioglu City Hospital, 59030 Tekirdag, Turkey

2. Institute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, D‑50937 Cologne, Germany

3. Department of General, University of Cologne, Faculty of Medicine and University Hospital Cologne, D‑50937 Cologne, Germany

4. Department I of Internal Medicine, Center for Integrated Oncology, University of Cologne, Faculty of Medicine and University Hospital Cologne, D‑50937 Cologne, Germany

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Oesophageal carcinoma;Pennathur;Lancet,2013

3. Continuing rapid increase in esophageal adenocarcinoma in England and Wales;Lepage;Am J Gastroenterol,2008

4. Prognostic factors and survival analysis in esophageal carcinoma;Tustumi;Arq Bras Cir Dig,2016

5. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis;He;Thorac Cancer,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An anoikis-related lncRNA signature may predict the prognosis, immune infiltration, and drug sensitivity in esophageal cancer;Heliyon;2024-05